Skip to main content
Erschienen in: Endocrine Pathology 1/2017

14.10.2016

Dopamine-Secreting Paraganglioma in the Retroperitoneum

verfasst von: Yusuke Matsuda, Noriko Kimura, Takanobu Yoshimoto, Yoshihiro Sekiguchi, Junzo Tomoishi, Ichiro Kasahara, Yoshihito Hara, Yoshihiro Ogawa

Erschienen in: Endocrine Pathology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Pheochromocytomas and paragangliomas, which exclusively produce dopamine, are very rare. Herein, we report for the first time a Japanese case of an exclusively dopamine-producing paraganglioma accompanied by detailed immunohistochemical analyses. A 70-year-old Japanese woman was referred to our hospital for functional examination of her left retroperitoneal mass. Her adrenal functions were normal, except for excessive dopamine secretion. After the tumorectomy, her dopamine level normalized. The histopathological diagnosis of the tumor was paraganglioma; this was confirmed by positive immunostaining of chromogranin A (CgA), tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH), and succinate dehydrogenase gene subunit B (SDHB). However, the immunostaining of CgA in the tumor cells showed peculiar dot-like staining located corresponding to Golgi complex in the perinuclear area, rather than the diffuse cytoplasmic staining usually observed in epinephrine- or norepinephrine-producing functional pheochromocytomas and paragangliomas. The immunohistochemical results suggested that the tumor cells had sparse neuroendocrine granules in the cytoplasm, resulting in inhibition of catecholamine synthesis from dopamine to norepinephrine in neurosecretory granules. This may be the mechanism responsible for exclusive dopamine secretion in the present case.
Literatur
1.
Zurück zum Zitat Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075, 2005.CrossRefPubMed Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075, 2005.CrossRefPubMed
2.
Zurück zum Zitat Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21:405–414, 2014.CrossRefPubMed Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21:405–414, 2014.CrossRefPubMed
3.
Zurück zum Zitat Kimura N, Capella C, DeLellis RA, Epstein JI, Gill A, Kawashima A, Koch C, Komminoth P, Lam A KY, Merino MJ, Mete O, Papathomas TG, Sadow P, Thompson LDR, Tischler AS, Williams MD, Young WF. Extra-adrenal paragangliomas. In: Lloyd RV, Kloppel G, Osamura RY, Rosai J, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2017, in press. Kimura N, Capella C, DeLellis RA, Epstein JI, Gill A, Kawashima A, Koch C, Komminoth P, Lam A KY, Merino MJ, Mete O, Papathomas TG, Sadow P, Thompson LDR, Tischler AS, Williams MD, Young WF. Extra-adrenal paragangliomas. In: Lloyd RV, Kloppel G, Osamura RY, Rosai J, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2017, in press.
4.
Zurück zum Zitat Poirier É, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg 216:340–346, 2013.CrossRefPubMed Poirier É, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg 216:340–346, 2013.CrossRefPubMed
5.
Zurück zum Zitat van Gelder T, Verhoeven GT, de Jong P, Oei HY, Krenning EP, Vuzevski VD, van den Meiracker AH. Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy. J Nucl Med 36:620–622, 1995.PubMed van Gelder T, Verhoeven GT, de Jong P, Oei HY, Krenning EP, Vuzevski VD, van den Meiracker AH. Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy. J Nucl Med 36:620–622, 1995.PubMed
6.
Zurück zum Zitat Smith SL, Slappy AL, Fox TP, Scolapio JS. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc 77:97–100, 2002.CrossRefPubMed Smith SL, Slappy AL, Fox TP, Scolapio JS. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc 77:97–100, 2002.CrossRefPubMed
7.
Zurück zum Zitat Tam V, Ng KF, Fung LM, Wong YY, Chan MH, Lam CW, Tam S, Lam CW. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem 42:73–77, 2005.CrossRefPubMed Tam V, Ng KF, Fung LM, Wong YY, Chan MH, Lam CW, Tam S, Lam CW. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem 42:73–77, 2005.CrossRefPubMed
8.
Zurück zum Zitat Yi JW, Oh EM, Lee KE, Choi JY, Koo do H, Kim KJ, Jung KC, Kim SY, Youn YK. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc 82:389–393, 2012.CrossRefPubMedPubMedCentral Yi JW, Oh EM, Lee KE, Choi JY, Koo do H, Kim KJ, Jung KC, Kim SY, Youn YK. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc 82:389–393, 2012.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Feldman JM, Blalock JA, Zern RT, Shelburne JD, Gaede JT, Farrell RE, Wells SA Jr Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol 72:175–185, 1979.CrossRefPubMed Feldman JM, Blalock JA, Zern RT, Shelburne JD, Gaede JT, Farrell RE, Wells SA Jr Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol 72:175–185, 1979.CrossRefPubMed
10.
Zurück zum Zitat Louthan O. Chromogranin a in physiology and oncology. Folia Biol 57:173–181, 2011. Louthan O. Chromogranin a in physiology and oncology. Folia Biol 57:173–181, 2011.
11.
Zurück zum Zitat Kimura N, Capella C, De Kriiger RR, Thompson LDR, Lam KY, Komminoth P, Tishler AS, Young Jr WF. Extra-adrenal sympathetic paraganglioma: superior and inferior paraaortic. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2004. Kimura N, Capella C, De Kriiger RR, Thompson LDR, Lam KY, Komminoth P, Tishler AS, Young Jr WF. Extra-adrenal sympathetic paraganglioma: superior and inferior paraaortic. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2004.
12.
Zurück zum Zitat Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington DC, 2011. Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington DC, 2011.
14.
Zurück zum Zitat Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162, 1986.PubMed Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162, 1986.PubMed
15.
Zurück zum Zitat van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147:85–94, 2002.CrossRefPubMed van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147:85–94, 2002.CrossRefPubMed
16.
Zurück zum Zitat Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol 23:4–14, 2012.CrossRefPubMed Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol 23:4–14, 2012.CrossRefPubMed
17.
Zurück zum Zitat van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764–771, 2009.CrossRefPubMedPubMedCentral van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764–771, 2009.CrossRefPubMedPubMedCentral
Metadaten
Titel
Dopamine-Secreting Paraganglioma in the Retroperitoneum
verfasst von
Yusuke Matsuda
Noriko Kimura
Takanobu Yoshimoto
Yoshihiro Sekiguchi
Junzo Tomoishi
Ichiro Kasahara
Yoshihito Hara
Yoshihiro Ogawa
Publikationsdatum
14.10.2016
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 1/2017
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9457-0

Weitere Artikel der Ausgabe 1/2017

Endocrine Pathology 1/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …